Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
| Autor: | Habek, Mario |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pediatrics Multiple Sclerosis Neurology Coronavirus disease 2019 (COVID-19) Dermatology Asymptomatic Multiple Sclerosis Relapsing-Remitting Chickenpox medicine Humans Immunologic Factors Multiple Sclerosis Relapsing-Remitting / drug therapy Alemtuzumab Neuroradiology Alemtuzumab / adverse effects SARS-CoV-2 business.industry Multiple sclerosis COVID-19 General Medicine medicine.disease Psychiatry and Mental health Multiple Sclerosis / drug therapy Neurology (clinical) Neurosurgery medicine.symptom business medicine.drug |
| Zdroj: | Neurological Sciences |
| ISSN: | 1590-3478 1590-1874 |
| DOI: | 10.1007/s10072-021-05495-6 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|